NCT07638748 · NOT YET RECRUITING

Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment

This trial is testing whether virtual reality sessions are a practical and acceptable way to support cognitive and physical rehabilitation in people with mild cognitive impairment or subjective cognitive decline. Researchers want to know if participants can tolerate and stick with the VR program, and whether it shows early signs of helping cognition, physical ability, or daily functioning. This is a feasibility study, meaning it is an early-stage test of whether the approach is workable, not a proven treatment.

You may qualify if

  • Clinical diagnosis of MCI (MoCA 18-26) or self-reported subjective cognitive decline (SCD)
  • Capacity to provide informed consent
  • Able to provide own transportation to sessions
  • Speaks and understands English
  • Ambulatory

You're excluded if

  • Uncontrolled seizures or epilepsy
  • Severe psychiatric illness or active suicidality
  • Inability to follow instructions or tolerate VR (severe motion sickness)
  • Cognitive impairment as a result of a known cause (e.g., dementia, stroke, Traumatic Brain Injury (TBI), medications, etc.)
  • Any condition that the research team determines would interfere with safe participation

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-06-10

View full record on ClinicalTrials.gov

All APOE4 clinical trials